Brazil has two health systems: private & public. The public system is called the “Unified Health System” (SUS) and its annual budget is approximately R$ 120 bi (US$ 60 bi).

SUS’ annual figures are like this:

  • 70% of the Brazilian population depend on SUS;
  • 5,900 hospitals;
  • 64,000 primary care units;
  • 2,3 billions ambulatory appointments;
  • 12 millions hospital admissions;
  • 9 millions chemo and radiotherapy procedures;
  • 300 millions laboratory tests;
  • 1 million CT scans and 160,000 MR;
  • 6.5 millions echographies
  • 8 millions hemodialyses procedures.

The health industry accounts for around 8% of Brazil’s GDP. SUS’ purchases are expect to grow in the coming years and will be surely followed by private sector expenditures.

Several companies are going to Brazil to develop and locally manufature medical devices and drugs. As the population has different health problems in relation to European and North American countries, the economics of the industry is specific and local research capabilities are in place, local R&D & manufacturing make sense.

Brazilian public sector organizations have a proven track record in providing assistance to African countries.

The opportunity…

  • To develop and manufacture medical devices and drugs in Brazil;
  • To partner with local research organizations, both public & private;
  • To partner with Brazilian organizations to jointly offer health services in Africa.